Live30 webinars are thirty minute presentations designed to update you on the latest innovations, applications and data in a fast yet interactive format.
Navigating and adapting to the constantly evolving regulatory landscape in cell and gene therapy manufacturing can pose critical barriers and challenges for developers and manufacturers. Failure to meet requirements can significantly drive up costs, motivating implementation of robust, reproducible and compliant processes. Over the last decade, several technological advancements have contributed to ease of scalability and highly efficient viral vector production protocols. In this webinar, Scott Cross, Dark Horse Consulting Group, and Shikha Mishra, Thermo Fisher Scientific will share their insights on regulatory compliance throughout the therapeutic development lifecycle, and best practices for producing high quality viral vectors at scale, for clinical and commercial applications.